Further enrichment analysis linked these genes to GTPases, pathways of non-small cell lung cancer, PD-L1 expression, and the PD-1 checkpoint, underscoring their potential impact on LUAD prognosis and the efficacy of PD-L1-targeted therapies (Supplementary Figure S1). This evidence concerns the gene CD274 and non-small cell lung carcinoma.